Short term salbutamol ingestion and supramaximal exercise in healthy women

British Journal of Sports Medicine

Volumn 40, Issue 7, 2006, Pages 627-631

  Le Panse, B ^b   Arlettaz, A ^b   Portier, H ^b   Lecoq, A M ^c   De Ceaurriz, J ^d   Collomp, K ^a,e  

^a Faculte du Sport et de l'Education Physique   (France)

^b UNIVERSITÉ D'ORLÉANS   (France)

^c Service de Physiopathologie de l'Exercice   (France)

^d Laboratoire National de Depistage du Dopage (LNDD)   (France)

^e Laboratoire National de Depistage du Dopage   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LACTIC ACID; PLACEBO; SALBUTAMOL;

ADULT; ANAEROBIC EXERCISE; ANAEROBIC METABOLISM; ARTICLE; BODY COMPOSITION; BODY WEIGHT; BONE DENSITOMETRY; BONE DENSITY; BONE MASS; BONE MINERAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; HUMAN EXPERIMENT; JOB PERFORMANCE; LACTATE BLOOD LEVEL; NORMAL HUMAN; SHORT COURSE THERAPY; SITTING;

ADRENERGIC BETA-AGONISTS; ADULT; ALBUTEROL; ANAEROBIC THRESHOLD; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXERCISE; EXERCISE TEST; FEMALE; HUMANS; LACTIC ACID;

EID: 33745822444     PISSN: 03063674     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjsm.2006.026237     Document Type: Article

References (20)

1. Baker P, Dalrymple R, Ingle D, et al. Use of an adrenergic agent to alter muscle and fat disposition in lambs. Fed Proc 1983;42:816.
2. Reeds P, Hay S, Dorward P, et al. The effects of β-agonists and antagonists on muscle growth and body composition of young rats. Comp Biochem Pnysiol 1988;89:337-41.
3. Ricks C, Dalrymple R, Baker P, et al. Use of a β-agonist to alter fat and muscle deposition in steers. J Anim Sci 1984;59:1247-55.
4. Martineau L, Horan M, Rothwell N, et al. Salbutamol, a β2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci 1992;83:615-21.
5. Caruso J, Signorile J, Perry A, et al. The effects of albuterol and isokinetic exercise on the quadriceps muscle group. Med Sci Sports Exerc 1995;27:1471-6.
6. Caruso J, Hamill J, De Garmo N. Oral albuterol dosing during the latter stages of a resistance exercise program. J Strength Cond Res 2005;19:102-7.
7. Le Panse B, Collomp K, Portier H, et al. Effects of short-term salbutamol ingestion during a Wingate test. Int J Sports Med 2005;26:518-23.
8. Bloomfield S, Girten B, Weisbrode S. Effects of vigorous exercise training and beta-agonist administration on bone response to nindlimb suspension. J Appl Physiol 1997;83:172-8.
9. Zeman R, Hirschman A, Hirschman M, et al. Clenbuterol, a beta 2-receptor agonist, reduces net bone loss in denervated hindlimbs. Am J Physiol 1991;261:E285-9.
10. Cavalie H, Lac G, Lebecque P, et al. Influence of clenbuterol on bone metabolism in exercised or sedentary rats. J Appl Physiol 2002;93:2034-7.
11. Kitaura T, Tsunekawa N, Kraemer W. Inhibited longitudinal growth of bones in young male rats by clenbuterol. Med Sci Sports Exerc 2002;34:267-73.
12. Bonnet N, Brunet-Imbault B, Arlettaz A, et al. Alteration of trabecular bone under chronic beta2 agonists treatment. Med Sci Sports Exerc 2005;37:1493-501.
13. Bonnet N, Benhamou CL, Brunet-Imbault B, et al. Severe bone alterations under beta2 agonist treatments: bone mass, microarchitecture and strength analyses in female rats. Bone 2005;37:622-33.
14. Caruso J, Hamill J, Yamauchi M, et al. Can albuterol help resistance exercise attenuate unloading-induced bone loss? J Strength Cond Res 2004;18:753-9.
15. Kraemer W, Ratamess N, French D. Resistance training for health and performance. Curr Sports Med Rep 2002;1:105-71.
16. 2- adrenoceptor agonist salmelerol are dependent on route of administration. Am J Physiol 1994;30:E475-84.
17. Yang Y, McElligott M. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J 1989;261:1-10.
18. Carter W, Lynch M. Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats. Metabolism 1994;43:1119-25.
19. Choo J, Horan M, Little R, et al. Anabolic effects of clenbuterol on skeletal muscle are mediated by β2-adrenoceptor activation. Am J Physiol 1992;263:E50-56.
20. Price A, Clissold S. Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs 1989;38:77-122.